Call Us!

+1 310-279-5152
+1 800-859-7036

 Call 1-800-859-7036 anytime to order or
discuss your options with our oncologists.

History of Escozine™

In 1980, blue scorpion serum was first researched by Michel Bordier in the Cuban province of Guantanamo. Bordier investigated the biological effects of blue scorpion serum in animals with cancerous tumors. Blue scorpion serum demonstrated extraordinary efficacy.

"The immune system of the benign cells increases, the malignant cells start dying and the tumors shrink or disappear," Bordier explained.

"We saw how some 85 percent of the [animals] survived."

Doctors began to consider the positive impact of blue scorpion serum upon the health of humans. In the early 1990s, a simple mixture of blue scorpion serum and distilled water called Escozul™ or Escozaul™ was tested on the first human patient and was found to shrink and then eliminate the tumor of a young Cuban woman. Ever since then it has been used by over 60,000 cancer patients worldwide.

Blue scorpion serum has been shown to promote additional health benefits including analgesic and anti-inflammatory effects. Blue scorpion serum has also been shown to have positive results with a wide variety of immune-system related diseases including:

• HIV
• Alzheimer’s Disease
• Multiple Sclerosis
• Muscular Dystrophy
• Arthritis

In 2003, CNN did a major story on blue scorpion serum and increased global awareness of the subject.

In 2004, the founders of Medolife began extensively researching blue scorpion serum. They were tremendously impressed by the results they observed.

Encouraged by the tremendous improvements in health they witnessed, the Medolife Corporation was founded in 2007 to make blue scorpion serum available to the world.

Since then, the Medolife Corporation has organized a blue scorpion reservation on the island of Hispaniola. This reservation offers the first consistent, large-scale source of blue scorpion serum with a high level of quality control.

Medolife is currently engaging in further research on blue scorpion serum with Swiss biotech laboratory, Atheris. We are always striving to find new and better ways to improve the already spectacular effectiveness of Escozine™.

The future of Escozine™ is bright and now this miracle is available to the world.

These claims have not been evaluated by the FDA. Escozine™ is not intended to diagnose, treat, cure, or prevent any disease.